Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?Edwin Uriel Suárez, Esperanza Lavilla, M. Tormo et al.|Annals of Hematology|2024Cited by 1
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registryAna Alfonso Piérola, David Martínez‐Cuadrón, Rebeca Rodríguez‐Veiga et al.|Leukemia|2025Cited by 1